Associations of insulin‐like growth factors, insulin‐like growth factor binding proteins and acid‐labile subunit with coronary heart disease
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: objective IGFs and their binding proteins (IGFBPs) are produced both systemically and locally by cells of the cardiovascular system. As growth promoters, they may play a role in atherosclerosis. design Case–control, cross‐sectional. patients A total of 95 nondiabetic male patients with coronary heart disease (CHD) and 92 probands from the Prospective Cardiovascular Münster (PROCAM) who were below the age of 60 years and matched by age, body mass index (BMI) and smoking habits measurements We analysed the strength and independence of associations of angiographically assessed presence of CHD with BMI, systolic and diastolic blood pressure, total, high‐density lipoprotein (HDL) and LDL cholesterol, triglycerides, lipoprotein(a), apolipoproteins A‐I and B, total and free IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐3, IGFBP‐5, acid‐labile subunit (ALS), insulin, C‐peptide, testosterone, DHEAS and sex hormone binding globulin. results Using multivariate statistical analysis, the presence of CHD had significant positive associations with total IGF‐I, IGFBP‐5, ALS and IGFBP‐3. These associations were independent of each other as well as of traditional risk factors, insulin and sex hormones. conclusion These observations may indicate a pathogenetic role of the GH/IGF axis in coronary atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Laughlin, G. A., Barrett-Connor, E., Criqui, M. H., & Kritz-Silverstein, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030967 · Cited by 374 · cited 4×
“It has to be emphasized that two recent prospective population studies made the opposite observation on IGF-I, namely low rather than high IGF-I levels were associated with an increased risk of myocardial infarction (Juul et al., 2002; Laughlin et al., 2004).”
BackgroundResultInfluential
Cited by
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Increase of circulating IGFBP-4 following genotoxic stress and its implication for senescence
Alessio, N., Squillaro, T., Di Bernardo, G., Galano, G., De Rosa, R., Melone, M. A., Peluso, G., & Galderisi, U. (2020) · eLife · doi:10.7554/elife.54523 · Cited by 51
“Moreover, exclusion criteria are also selected to reduce variability, since the excluded conditions could alter IGFBP levels (Baxter, 2014; Fischer et al., 2004; Renehan et al., 2004).”
Background
Metadata
- Authors
- Fischer, F., Schulte, H., Mohan, S., Tataru, M., Köhler, E., Assmann, G., & Von Eckardstein, A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2004-10-15
- Volume
- 61
- Issue
- 5
- Pages
- 595-602
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2043437731
- Cited by
- 80
- References
- 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.